Identity
- Security key
- 11840
- Ticker
- AQST
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2018-07-25
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- AQST
Detail
Enriched 2026-08-14 20:47
- Market cap
- $530,914,271.04
- Shares outstanding (class)
- 125,466,988
- Shares outstanding (weighted)
- 125,511,648
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 147
- Location
- WARREN, NJ
- Homepage
- https://www.aquestive.com
- Description
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
Market cap and share counts drift.